Medartis Holding AG (SWX:MED)
Switzerland
· Delayed Price · Currency is CHF 80.30
-3.50 (-4.18%)
Mar 9, 2026, 5:36 PM CET
Medartis Holding AG Revenue
Medartis Holding AG had revenue of 123.04M CHF in the half year ending June 30, 2025, with 19.17% growth. This brings the company's revenue in the last twelve months to 236.34M, up 7.29% year-over-year. In the year 2024, Medartis Holding AG had annual revenue of 224.83M with 6.05% growth.
Revenue (ttm)
236.34M
Revenue Growth
+7.29%
P/S Ratio
4.22
Revenue / Employee
204.10K
Employees
1,158
Market Cap
998.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 224.83M | 12.83M | 6.05% |
| Dec 31, 2023 | 212.01M | 29.18M | 15.96% |
| Dec 31, 2022 | 182.82M | 22.94M | 14.35% |
| Dec 31, 2021 | 159.88M | 32.23M | 25.25% |
| Dec 31, 2020 | 127.65M | -2.50M | -1.92% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Galderma Group AG | 4.16B |
| Lonza Group AG | 6.53B |
| Tecan Group AG | 906.60M |
| Aevis Victoria | 955.96M |
| SKAN Group AG | 332.13M |
| Kuros Biosciences AG | 103.35M |